The Effects of Hesperidin Supplementation on Cardiovascular Risk Factors in Adults: A Systematic Review and Dose–Response Meta-Analysis Publisher



Khorasanian AS¹ ; Fateh ST² ; Gholami F³ ; Rasaei N³ ; Gerami H^{4, 5} ; Khayyatzadeh SS^{4, 6} ; Shiraseb F³ ; Asbaghi O^{7, 8}
Source: Frontiers in Nutrition Published:2023

Abstract

Hesperidin is a naturally occurring bioactive compound that may have an impact on cardiovascular disease risks, but the evidence is not conclusive. To investigate further, this study aimed to explore the effects of hesperidin supplementation on cardiovascular risk factors in adults. A comprehensive search was conducted up to August 2022 using relevant keywords in databases such as Scopus, PubMed, Embase, Cochrane Library, and ISI Web of Science for all randomized controlled trials (RCTs). The results showed that hesperidin supplementation had a significant effect on reducing serum triglyceride (TG), total cholesterol (TC), low-density cholesterol (LDL), tumor necrosis factor-alpha (TNF-α), and systolic blood pressure (SBP), whereas weight was increased. However, no significant effect was observed on high-density cholesterol (HDL), waist circumference (WC), fasting blood glucose (FBG), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), C-reactive protein (CRP), interleukin-6 (IL-6), body mass index (BMI), and diastolic blood pressure (DBP). The study also found that an effective dosage of hesperidin supplementation was around 1,000 mg/d, and a more effective duration of supplementation was more than eight weeks to decrease insulin levels. Furthermore, the duration of intervention of more than six weeks was effective in decreasing FBG levels. Copyright © 2023 Khorasanian, Fateh, Gholami, Rasaei, Gerami, Khayyatzadeh, Shiraseb and Asbaghi.